The pharmaceutical stocks once again fell collectively!
Medical Network August 7th Recently, affected by the problem vaccine incident, the most fierce in the stock market, is the pharmaceutical sector. And just yesterday, pharmaceutical stocks once again collectively fell!
The author's data on the stocks of Wande found that the pharmaceutical sector fell really not so much. Whether it is big to the pharmaceutical industry, or focus on innovative drugs, generic drugs, are all falling.
What impact is it, so that the pharmaceutical sector, which has the reputation of the sunrise industry, has fallen so badly? The author is not a professional, and this issue cannot be conclusive. We can sort out some recent events that may have occurred in the past. Find the answer.
1, longevity biological problem vaccine event
The problem vaccine incident, contracted the focus of public opinion for nearly a month.
Long-lived creatures are currently guilty of three crimes, and the risk of delisting is not ruled out in the future. The first crime is the vaccination of rabies vaccine last year; the second sin is the fraud of rabies vaccine in July this year; the third sin is the investigation of the confiscation of violations. .
The State Food and Drug Administration ordered Changsheng Biological to suspend production, file an investigation, and organize all vaccine production. enterprise Flight check.
At present, the Changchun New District Public Security Bureau pleaded guilty to production and sales of inferior drugs, and 18 suspects including the chairman of Changsheng Biological were invited to the procuratorate for approval.
Recently, Changsheng Biotechnology announced that at present, in addition to the baibai broken combination vaccine, freeze-dried human rabies vaccine products were ordered to suspend production, the company decided to take full and independent production of other products of the company, the above production workshops during the suspension period Check and correct, carry out comprehensive and thorough rectification.
2, valsartan carcinogen event
Recently, valsartan bulk drug detection of 'toxic' impurity incidents has also become the focus of public opinion.
Since the July 5th '缬沙坦事件' fermentation began, so far, Huahai Pharmaceutical has issued several announcements for this incident. The company said that from the perspective of risk prevention, the company decided to take the initiative to recall the listing at home and abroad. Shatan raw material medicine.
On July 29, the State Food and Drug Administration issued a notice, the domestic production of a total of 6 preparations for the use of Huahai Pharmaceutical valsartan bulk drug, Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. produced valsartan capsules (National Medicine Zhunzi H20103521 NDMA has exceeded the limit in the listed products of the other five manufacturers, which are:
The above five pharmaceutical manufacturers have stopped using Huahai Pharmaceutical's valsartan bulk drug, recalled according to regulations. drug.
3, the United States health 'Fake doctor' storm
On July 29th, the micro-signal point of view released "The Health of the Year: If a person dies, you can only earn one time!", the article points to the health of the United States - the medical examiner is undocumented, even using others The practice certificate helps undocumented personnel to go to work, etc. In an instant, the public opinion is stunned.
Subsequently, the US Health Responsive to the Shenzhen Stock Exchange said that the company does not have undocumented employment, holding the wrong certificate or holding an expired license to work.
Yesterday (August 6th), the US Announcement of Health Announced that Guangzhou Mei Nian Fuhai Clinic received the notice of rectification of the Guangzhou Tianhe District Health and Welfare Bureau. The notice confirmed that the Mei Nian Health Mei Nian Fu Hai Clinic was Famous doctor Health, physical examination report without doctor's handwritten signature, illegal implementation of CT radiology treatment activities and other three major violations.
Two diametrically opposite announcements from the Health of the United States made the scene look very embarrassing. The 'fake doctor' was confirmed to be not only being beaten, but also falling stock prices after the health of the United States.
Last week, the US health stock price fell 24.88%, the market value shrank by nearly 17 billion yuan, yesterday (August 6) continued to fall after the opening, closing price of 16 yuan, down 1.84%.
As a sunrise industry, it has always been medicine The sector is highly sought after by the funds, and with the aging of China's population, the state encourages innovative drugs, guarantees the supply of high-quality generic drugs, and prioritizes the review and approval of the policy, the market is also generally optimistic about the pharmaceutical sector.
Recently, many pharmaceutical stocks have fallen sharply, and Baima Pharmaceuticals, which has been favored by the market, is no exception. Next, whether the drug and drink market can continue, let us pay attention to it.
